文献速递肝胆胰外科

腹腔镜肝切除术是否适用于直径大于10厘米的巨大肝血管瘤?

Is laparoscopic hepatectomy suitable for giant hepatic hemangioma larger than 10 cm in diameter?
PubMed 文献 · Surg Endosc · 2019-06-03

本研究回顾了2011年9月至2018年5月共58例直径大于10厘米的巨大肝血管瘤行腹腔镜手术的患者,按手术难度评分分为高难度组(28例)和低难度组(30例)。结果显示高难度组术中出血量、肝门阻断时间及阻断率更高,住院时间和出院时间更长,但两组在性别、年龄、ASA分级、肿瘤大小、手术时间、中转率、输血率及术后并发症方面无差异。结论认为尽管存在较大困难和风险,腹腔镜治疗巨大肝血管瘤是安全可行的。

要点

  • 巨大肝血管瘤(>10 cm)行腹腔镜手术在高难度组出血量及肝门阻断率更高。
  • 高难度组住院时间和出院时间较低难度组延长。
  • 两组术后并发症及酶学指标无显著差异,总体安全可行。

核心结论

  • 尽管客观存在较大困难和风险,腹腔镜治疗巨大肝血管瘤是安全可行的。

研究设计与样本

  • 回顾性队列研究,纳入2011年9月至2018年5月58例直径大于10厘米的巨大肝血管瘤行腹腔镜手术的患者,按手术难度评分分为高难度组(28例)和低难度组(30例)。

主要发现

  • 高难度组术中出血量显著高于低难度组(285.7 ± 224.0 vs 189.6 ± 157.6 ml,p = 0.007)。
  • 高难度组肝门阻断时间 longer than 低难度组(25.4 ± 8.8 vs 20.6 ± 7.3 min,p = 0.001),肝门阻断率也更高(71.4% vs 33.3%,p = 0.004)。
  • 低难度组住院天数短于高难度组(6.3 ± 1.6 vs 8.2 ± 1.4 天,p = 0.000),出院时间也 shorter(16.4 ± 5.5 vs 21.9 ± 4.6 小时,p = 0.019)。
  • 两组在性别、年龄、ASA分级、肿瘤大小、手术时间、中转率、术中及术后输血率、术后并发症方面无差异。
  • 两组术后酶学参数无显著差异。

临床怎么用

  • 对于巨大肝血管瘤,腹腔镜手术可在有经验的中心开展,但高难度病例需警惕出血和延长住院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical treatment of giant hepatic hemangioma larger than 10 cm in diameter often requires major laparoscopic liver resection (LLR), which is very difficult and has a high risk of bleeding. There is no consensus as to whether giant hepatic hemangioma is an indication or a contraindication for laparoscopic surgery. METHODS: From 2011/09 to 2018/05, 58 patients with giant hepatic hemangioma larger than 10 cm underwent laparoscopic surgery. They were divided into high-difficulty (HD) group and low-difficulty (LD) group according to the operation difficulty score. The perioperative data of the two groups were analyzed and compared. RESULTS: There were 30 patients in the LD group and 28 in the HD group. No differences were showed in sex, age, ASA grade, tumor size, operation time, conversion rate, intraoperative and post-operative blood transfusion rate, and post-operative complications between the two groups. The amount of bleeding in the HD group was significantly higher than that in the LD group (285.7 ± 224.0 vs 189.6 ± 157.6 ml, p = 0.007). The time of hepatic hilar occlusion in the HD group was longer than that in the LD group (25.4 ± 8.8 vs 20.6 ± 7.3 min, p = 0.001), and the rate of hepatic hilar occlusion in the HD group was also higher than that in the LD group (71.4% vs 33.3%, p = 0.004). The incidence of hospitalization days and discharge time in the LD group were shorter than those in the HD group (6.3 ± 1.6 vs 8.2 ± 1.4 days, p = 0.000; 16.4 ± 5.5 vs 21.9 ± 4.6 h, p = 0.019). There was no significant difference in enzymatic parameters between the two groups after operation. CONCLUSIONS: Although there are great difficulties and risks objectively, laparoscopic treatment of giant hepatic hemangioma is safe and feasible.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Jinhuan Y, Gang D, Binyao S, et al. Is laparoscopic hepatectomy suitable for giant hepatic hemangioma larger than 10 cm in diameter? Surg Endosc. 2019. PMID: 31161290. doi:10.1007/s00464-019-06880-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。